Takeda Pairs with Novavax to Roll Out Coronavirus Vaccine in Japan, Wins 30 Billion Yen in Govt Funding

To read the full story

• Sign In
• Subscribe

Related Article

• Nuvaxovid Gets Label Update to Allow Primary Inoculations in Ages 12 and Older
  July 21, 2022

• Japan Plans to Lower Minimum Age for Novavax Jab to 12
  July 19, 2022

• Novavax Vaccine Officially Added to Japan’s Free COVID-19 Inoculation Program
  May 26, 2022

• Novavax COVID-19 Jab OK’ed for 1st to 3rd Shot Use under Free Program
  April 28, 2022

• Japan Approves Novavax’s COVID-19 Vaccine; Distribution to Start in Late May
  April 19, 2022

• Novavax COVID-19 Vaccine Clears MHLW Panel, Approval Expected Soon
  April 19, 2022

• Japan to Start Distributing Novavax Jab from Late May, If Approved
  April 7, 2022

• Novavax’s COVID-19 Vaccine Up for PAFSC Review on Regular Pathway
  April 5, 2022

• Novavax’s COVID-19 Vaccine Filed in Japan: Takeda
  December 16, 2021

• Japan Strikes Deal for 150 Million Novavax Vaccine Doses, Supply Could Start Early Next Year
  September 7, 2021

• Takeda Submits Positive Japan Data for Approval-Pending Moderna Vaccine
  May 11, 2021

• Japan to Review Moderna Vaccine with Top Priority, May OK Possible: Minister
  March 8, 2021

• Takeda Submits NDA for Moderna Vaccine in Japan
  March 5, 2021

• Takeda Launches Japan PI/II Trial of Novavax COVID-19 Vaccine
  February 25, 2021

• Moderna’s COVID-19 Shot Enters Clinical Trial in Japan: Takeda
  January 21, 2021

• Takeda Slated to Launch Japan PI/II for Moderna Shot in January
  December 22, 2020

• Takeda Prepping for Japan Trial of Moderna COVID-19 Vaccine: MHLW Official
  November 18, 2020

• Japan to Receive 50 Million Doses of Moderna COVID-19 Vaccines via Takeda
  October 29, 2020

• AMED to Fund 7 More Company-Led COVID-19 Vaccine Projects Including Takeda, Daiichi Sankyo
  September 2, 2020